AbbVie will participate in the Wells Fargo 21st Annual Healthcare Conference on September 9, 2026. The company's management will engage in a fireside chat at 9:15 a.m. Central time, which will be broadcast live via AbbVie's Investor Relations website. This event offers investors insight into AbbVie's current initiatives and future plans in healthcare innovation, particularly in immunology, neuroscience, oncology, and aesthetics. An archived version of the presentation will also be accessible later the same day.
If you retire before age 62, Social Security won't pay benefits until then, leaving a gap in income. Three ETFs—SPYI, DGRW, and HDV—offer monthly or quarterly dividends to generate income during this period. SPYI provides high monthly yields through ...
Investing in three blue-chip dividend stocks—Altria, AbbVie, and Chevron—each paying dividends quarterly on different schedules, can create a monthly income stream throughout the year. Altria pays in January, April, July, and October with a high yiel...
With inflation expected to remain high, five Dividend Aristocrats—companies with 25+ years of rising dividends—are recommended for investors seeking stable income and growth. These firms, including AbbVie, Chevron, PepsiCo, Procter & Gamble, and Targ...
AbbVie has submitted an application to the European Medicines Agency (EMA) for approval of SKYRIZI (risankizumab) as a subcutaneous induction treatment for adults with moderately to severely active Crohn's disease. This follows positive results from ...
